Shoulder Innovations

Shoulder Innovations News

News

0

Ticker

SI

ISIN

US82537J1088

Chiffre d'affaires Résultat net P/E P/S EBIT Dividende Achats de membres du conseil Actions Capitalisation boursière Endettement Passifs Capitaux propres AAQS Effectifs ROE ROA ROCE News Documents

Actualités Eulerpool Shoulder Innovations

Actualités de l'action Shoulder Innovations

Shoulder Innovations est suivi par de nombreux journalistes et investisseurs dans le monde. Nous rassemblons ici les dernières actualités concernant Shoulder Innovations.

Communiqués de presse relatifs à l'action Shoulder Innovations

Shoulder Innovations publie régulièrement sur son site web des communiqués pertinents pour les investisseurs.

Shoulder Innovations News 2026

Cette page contient toutes les actualités actuelles, analyses et communiqués de presse pour l'action Shoulder Innovations (SI, ISIN : US82537J1088). Cela inclut les actualités Eulerpool, les analyses d'entreprise et les communiqués de presse officiels. Les données sont mises à jour régulièrement pour fournir aux investisseurs un aperçu complet des derniers développements chez Shoulder Innovations.

Shoulder Innovations Action

Shoulder Innovations Shoulder Innovations Inc generates revenue through its advanced implant systems for shoulder arthroplasty, specifically the aTSA and rTSA systems, which address patient and surgeon needs with customizable configurations for anatomic or reverse procedures. The company's ecosystem includes enabling technologies, instrument systems, specialized support, and surgeon-to-surgeon collaboration, enhancing preoperative planning, implant design, and procedural efficiency across the care chain. Its InSet Glenoid technology forms the foundational element of these systems, supporting comprehensive surgical solutions for healthcare providers. The firm targets hospitals and surgical centers as primary buyers, leveraging its commercial-stage medical technology focus to serve the shoulder surgical care market. The company's product portfolio centers on aTSA and rTSA systems, designed to improve core components of shoulder surgical care, with InSet Glenoid as the cornerstone of its implant solutions. These systems are sold to healthcare institutions seeking advanced surgical tools that streamline procedures and improve patient outcomes. Shoulder Innovations Inc capitalizes on its ecosystem approach, bundling implant systems with enabling technologies and support services to create a cohesive offering for medical professionals. The firm’s commercial-stage position allows it to directly engage with hospitals and surgical centers as key customers in the healthcare equipment and supplies sector. Shoulder Innovations Inc's revenue model relies on selling its advanced implant systems, including aTSA and rTSA, alongside InSet Glenoid technology, to hospitals and surgical centers. The company emphasizes procedural efficiency and preoperative planning through its ecosystem, which includes instrument systems and surgeon collaboration tools. By focusing on shoulder arthroplasty, the firm targets a specialized segment within the healthcare market, offering tailored solutions that address both patient requirements and surgical workflow optimization. The company’s products are designed to integrate seamlessly into existing surgical practices, enhancing care delivery across the shoulder surgical care chain.